Search
for
Sort by
Research 151–180 of 1000+
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Baricitinib: A Review in Severe Alopecia Areata
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Successful treatment of resistant alopecia totalis with tofacitinib
- Novel investigational drugs for alopecia areata and future perspectives
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Alopecia areata
- Current Treatments for Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- Alopecia Areata Barbae in a Nutshell
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata